In recent years, there has been growing media coverage of, and opportunity for, riders specialising in ultra-endurance events ...
The Unified Patent Court and unitary patent have been a reality now since 1 June 2023. For our latest digested thoughts on the UPC and review of ...
12d
OncoZenge AB: OncoZenge AB advances global patent strategy for BupiZenge with filings in 17 markets
OncoZenge AB (publ) ("OncoZenge" or "the Company") today announces that it has entered the national and regional phase of its Patent Cooperation Treaty (PCT) application for BupiZenge in 17 ...
Smart Health Dental tops Investopedia’s list of the best dental insurance companies for 2026, followed closely by Delta ...
In-depth guide to the best endpoint encryption software for 2026 — features, pros, cons, and best-fit use cases for eight ...
A practical guide to endpoint encryption in 2026 — why management is the product, ten options by fit, BitLocker’s real role, ...
The 10 best device control and USB security tools of 2026 scored on granularity, DLP integration, and OT fit — plus the ownership changes to check first.
“Pay-to-ride” case takes another turn as five-year bans for former Vini Zabù managers are overturned
Angelo Citracca and Luca Scinto will no longer serve the five-year suspensions imposed on them over the Vini Zabù ...
Opportunities include integrated PDX platforms, humanized models, organoid pairing, AI analytics, annotated biobanks, precision oncology, and expansion across emerging research hubs.Dublin, Sept. 11, ...
Chelsea appear to be an improvement on last season's side, although there is still significant room for refinement. Come back ...
Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF), the London-listed biopharmaceutical company, has been granted a Notice of Allowance by the European Patent Office for a composition-of-matter patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results